CanSino Biologics Delivers COVID-19 Vaccine To Mexico For Late-stage Trial

News18 Logo

MEXICO CITY: Mexico has acquired the primary doses of a COVID-19 vaccine candidate from Chinese language pharmaceutical firm CanSino Biologics Inc. for a late stage-trial on between 10,000 and 15,000 volunteers, international minister Marcelo Ebrard stated on Tuesday.

The nation goals to vaccinate practically all of its inhabitants towards COVID-19 by the tip of 2021 after reaching accords with pharmaceutical firms and the World Well being Group-backed COVAX plan.

“On October 30, the primary doses had been acquired to hold out section three of medical trials of the candidate vaccine from Cansino Bio,” Ebrard stated at a information convention, including that it might be one of many world’s largest COVID-19 medical trials.

Disclaimer: This submit has been auto-published from an company feed with none modifications to the textual content and has not been reviewed by an editor